A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants

GSK Investigational Site, Bayamón

GSK Investigational Site, Jefferson Hills

GSK Investigational Site, Pittsburgh

GSK Investigational Site, Pittsburgh

GSK Investigational Site, Pittsburgh

GSK Investigational Site, N. Huntingdon

GSK Investigational Site, Cranberry Township

GSK Investigational Site, Spartanburg

GSK Investigational Site, Charleston

GSK Investigational Site, Greenville

GSK Investigational Site, Saint Augustine

GSK Investigational Site, Pensacola

GSK Investigational Site, Miami

GSK Investigational Site, Tampa

GSK Investigational Site, Bardstown

GSK Investigational Site, Louisville

GSK Investigational Site, Lexington

GSK Investigational Site, Cincinnati

GSK Investigational Site, Mankato

GSK Investigational Site, Missoula

GSK Investigational Site, Norfolk

GSK Investigational Site, Hastings

GSK Investigational Site, New Orleans

GSK Investigational Site, Covington

GSK Investigational Site, Lafayette

GSK Investigational Site, Haughton

GSK Investigational Site, Jonesboro

GSK Investigational Site, Tulsa

GSK Investigational Site, Dallas

GSK Investigational Site, Houston

GSK Investigational Site, Houston

GSK Investigational Site, Houston

GSK Investigational Site, Richmond

GSK Investigational Site, Dickinson

GSK Investigational Site, McAllen

GSK Investigational Site, Brownsville

GSK Investigational Site, Nampa

GSK Investigational Site, Layton

GSK Investigational Site, Roy

GSK Investigational Site, Syracuse

GSK Investigational Site, South Jordan

GSK Investigational Site, Salt Lake City

GSK Investigational Site, Los Angeles

GSK Investigational Site, Caguas

GSK Investigational Site, Ponce

GSK Investigational Site, San Juan